Strategy-confirming Study of BMS-955176 to Treat HIV-1 Infected Treatment-experienced Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this study is to evaluate whether the combination of BMS-955176 with atazanavir (ATV) \[with or without ritonavir (RTV)\] and dolutegravir (DTG) is efficacious, safe, and well-tolerated in HIV-1 infected treatment experienced adults.
Epistemonikos ID: c5381f7611f2caea345cd7db244b3d3d264f0fdf
First added on: May 12, 2024